- Home
- CDNA vs EMD Comparison
CDNA vs EMD Comparison
Compare CDNA & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- EMD
- Stock Information
- Founded
- CDNA 1998
- EMD 2003
- Country
- CDNA United States
- EMD United States
- Employees
- CDNA N/A
- EMD N/A
- Industry
- CDNA Medical Specialities
- EMD Finance/Investors Services
- Sector
- CDNA Health Care
- EMD Finance
- Exchange
- CDNA Nasdaq
- EMD Nasdaq
- Market Cap
- CDNA 712.2M
- EMD 604.6M
- IPO Year
- CDNA 2014
- EMD N/A
- Fundamental
- Price
- CDNA $13.53
- EMD $10.43
- Analyst Decision
- CDNA Buy
- EMD
- Analyst Count
- CDNA 8
- EMD 0
- Target Price
- CDNA $26.86
- EMD N/A
- AVG Volume (30 Days)
- CDNA 1.5M
- EMD 248.5K
- Earning Date
- CDNA 11-03-2025
- EMD 01-01-0001
- Dividend Yield
- CDNA N/A
- EMD 10.25%
- EPS Growth
- CDNA N/A
- EMD N/A
- EPS
- CDNA 1.00
- EMD N/A
- Revenue
- CDNA $340,826,000.00
- EMD N/A
- Revenue This Year
- CDNA $13.02
- EMD N/A
- Revenue Next Year
- CDNA $12.85
- EMD N/A
- P/E Ratio
- CDNA $13.56
- EMD N/A
- Revenue Growth
- CDNA 14.72
- EMD N/A
- 52 Week Low
- CDNA $10.96
- EMD $7.85
- 52 Week High
- CDNA $32.97
- EMD $9.55
- Technical
- Relative Strength Index (RSI)
- CDNA 52.36
- EMD 60.42
- Support Level
- CDNA $13.12
- EMD $10.16
- Resistance Level
- CDNA $13.80
- EMD $10.49
- Average True Range (ATR)
- CDNA 0.67
- EMD 0.09
- MACD
- CDNA 0.16
- EMD 0.01
- Stochastic Oscillator
- CDNA 63.39
- EMD 80.30
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.